The efficacy and safety of abiraterone acetate in patients with high-risk prostate cancer: a meta-analysis based on six randomized control trials

BACKGROUND: Abiraterone acetate, a CYP17 enzyme inhibitor, can block the synthesis of androgens in the adrenal gland, prostate, and testis. The purpose of this study was to investigate the efficacy and safety of abiraterone acetate in high-risk prostate cancer patients, including metastatic castrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Guobin, Xuan, Zijun, Li, Zhiqin, Huang, Shuitong, Chen, Guangming, Wu, Yonglu, Chen, Xianxi, Liang, Zhijin, Wu, Aiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475664/
https://www.ncbi.nlm.nih.gov/pubmed/32944530
http://dx.doi.org/10.21037/tau-20-1058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475664/
https://www.ncbi.nlm.nih.gov/pubmed/32944530
http://dx.doi.org/10.21037/tau-20-1058

Ejemplares similares